A Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of T3D-959 in Subjects with Mild to Moderate Alzheimer's Disease

Administered By

Awarded By

Contributors

Start/End

  • November 6, 2018 - June 30, 2019